Results 121 to 130 of about 23,073,058 (182)

RESULTS OF THE PHARMACOECONOMIC STUDY OF MEDICAL CARE FOR END-STAGE RENAL FAILURE PATIENTS IN NEED OF DIALYSIS

Разработка и регистрация лекарственных средств, 2019
Budget impact analysis and cost-utility analysis for the therapy of end-stage renal failure by methods of peritoneal dialysis and hemodialysis were performed by means of a developed analytical model of decision making.
G. T. Abdrashitova, R. S. Skulkova
doaj  

Use of fendivia transdermal therapeutic system in Russian patients with malignant neoplasms during palliative care: Pharmacoeconomic aspects

Терапевтический архив, 2014
AIM: To make a comparative clinical and economic assessment of a transdermal therapeutic system (TTS) for fendivia and traditional opioid analgesics in patients with malignant neoplasms (MN) during palliative care. Materials and methods. Pharmacoeconomic
V V Riazhenov, G R Abuzarova, S G Gorokhova, I V Emchenko, N V Matveev   +4 more
doaj  

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention. [PDF]

J Headache Pain
Guerzoni S, Pellesi L, Giannessi L, Lo Castro F, Olivieri MC, Degli Esposti L, Gandolfi F.   +6 more
europepmc   +1 more source

Pharmacoeconomic Analysis of Osimertinib Compared to Earlier-Generation EGFR Inhibitors in EGFR-Mutated NSCLC: A Systematic Review. [PDF]

Cancer Med
Perrotta N, Coluccia A, Rossi F, Amato G, Polito G.   +4 more
europepmc   +1 more source

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS

, 2015
Pharmacoeconomic study of treatment primary open-angle glaucoma with carbonic anhydrise inhibitors by mean of costefficacy and budget impact analysis.
V. G. Serpik, A. Yu. Kulikov
core  

Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice. [PDF]

Glob Reg Health Technol Assess
Ruiz-Medrano J, Puertas M, Hinojosa-Gonzalez M, Moreno-Alboran C, Ruiz-Moreno JM.   +4 more
europepmc   +1 more source

Pharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies

Pharmacoeconomic data may be obtained within the context of randomised clinical trials (RCTs) and from effectiveness studies in the `real world'. The differences between the 2 types of study design have implications for the types of data that can be ...
Lori Frank, Dennis A. Revicki
core  

Pharmacoeconomic Analysis of Medicines Used for Bronchial Asthma in Children in Kazakhstan. [PDF]

J Mother Child
Serikbayeva E, Suyunov N, Makhatov B, Atimtaikyzy A, Ibragimova A, Abdullaeva M.   +5 more
europepmc   +1 more source

Pharmacoeconomic Analysis of Brigatinib versus Alectinib in First‑Line Treatment of Anaplastic Lymphoma Kinase‑Positive Advanced Non‑Small‑Cell Lung Cancer in China. [PDF]

Oncol Ther
Chai Q, Gu C, Hernandez L, Zhang YJ.
europepmc   +1 more source

Model-based pharmacoeconomic analysis of anti-VEGF strategies for neovascular age-related macular degeneration: a value-based comparison of real-world administration approaches. [PDF]

BMJ Open
Gismero Moreno SM, Jódar Sánchez F, García-Agua Soler N, Rivas Ruiz F, Garcia-Ruiz AJ.   +4 more
europepmc   +1 more source